Home LiteratureArticle Details
PMID: 18505921 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases.

Molecular cancer research : MCR ·Vol. 6 ·No. 5 ·2008-05-00 ·Pages 760-9

Xu L, Shen SS, Hoshida Y, Subramanian A, Ross K, Brunet JP, Wagner SN, Ramaswamy S, Mesirov JP, Hynes RO

Abstract

Metastasis is the deadliest phase of cancer progression. Experimental models using immunodeficient mice have been used to gain insights into the mechanisms of metastasis. We report here the identification of a "metastasis aggressiveness gene expression signature" derived using human melanoma cells selected based on their metastatic potentials in a xenotransplant metastasis model. Comparison with expression data from human melanoma patients shows that this metastasis gene signature correlates with the aggressiveness of melanoma metastases in human patients. Many genes encoding secreted and membrane proteins are included in the signature, suggesting the importance of tumor-microenvironment interactions during metastasis.

MeSH Terms
Animals Cell Line, Tumor Disease Models, Animal Gene Expression Profiling Gene Expression Regulation, Neoplastic Humans Melanoma/pathology Mice Mice, SCID Models, Biological Neoplasm Metastasis Neoplasm Transplantation Treatment Outcome
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Xu Lei
Howard Hughes Medical Institute, Center for Cancer Research, Cambridge, MA, USA.
Shen Steven S
Hoshida Yujin
Subramanian Aravind
Ross Ken
Brunet Jean-Philippe
Wagner Stephan N
Ramaswamy Sridhar
Mesirov Jill P
Hynes Richard O
References (26)
26 references, click to expand
  1. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer.
    Cancer Res. 2005 Oct 15;65(20):9155-8 PMID: 16230372
  2. Genes that mediate breast cancer metastasis to lung.
    Nature. 2005 Jul 28;436(7050):518-24 PMID: 16049480
  3. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited.
    Nat Rev Cancer. 2003 Jun;3(6):453-8 PMID: 12778135
  4. Molecular portraits of human breast tumours.
    Nature. 2000 Aug 17;406(6797):747-52 PMID: 10963602
  5. Genomic analysis of metastasis reveals an essential role for RhoC.
    Nature. 2000 Aug 3;406(6795):532-5 PMID: 10952316
  6. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis.
    Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9023-8 PMID: 16757564
  7. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
    Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74 PMID: 11553815
  8. A multigenic program mediating breast cancer metastasis to bone.
    Cancer Cell. 2003 Jun;3(6):537-49 PMID: 12842083
  9. Tumor metastasis: mechanistic insights and clinical challenges.
    Nat Med. 2006 Aug;12(8):895-904 PMID: 16892035
  10. Dissemination and growth of cancer cells in metastatic sites.
    Nat Rev Cancer. 2002 Aug;2(8):563-72 PMID: 12154349
  11. Cancer metastasis: building a framework.
    Cell. 2006 Nov 17;127(4):679-95 PMID: 17110329
  12. Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas.
    Anticancer Res. 1997 Mar-Apr;17(2B):1319-30 PMID: 9137492
  13. Selection of successive tumour lines for metastasis.
    Nat New Biol. 1973 Apr 4;242(118):148-9 PMID: 4512654
  14. A molecular signature of metastasis in primary solid tumors.
    Nat Genet. 2003 Jan;33(1):49-54 PMID: 12469122
  15. Gene expression profiling predicts clinical outcome of breast cancer.
    Nature. 2002 Jan 31;415(6871):530-6 PMID: 11823860
  16. GenePattern 2.0.
    Nat Genet. 2006 May;38(5):500-1 PMID: 16642009
  17. A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice.
    J Natl Cancer Inst. 1984 Apr;72(4):913-7 PMID: 6584666
  18. Proteomic applications for the early detection of cancer.
    Nat Rev Cancer. 2003 Apr;3(4):267-75 PMID: 12671665
  19. Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma.
    Int J Dev Biol. 2005;49(2-3):173-80 PMID: 15906230
  20. Cancer spread and micrometastasis development: quantitative approaches for in vivo models.
    Bioessays. 2002 Oct;24(10):885-93 PMID: 12325121
  21. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
    Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 PMID: 16199517
  22. More powerful procedures for multiple significance testing.
    Stat Med. 1990 Jul;9(7):811-8 PMID: 2218183
  23. A Wnt-er wonderland--the complexity of Wnt signaling in melanoma.
    Cancer Metastasis Rev. 2005 Jun;24(2):237-50 PMID: 15986134
  24. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants-or both?
    Cell. 2003 Jun 27;113(7):821-3 PMID: 12837240
  25. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts.
    Cancer Res. 1984 Aug;44(8):3584-92 PMID: 6744281
  26. Gene expression profiles of primary breast tumors maintained in distant metastases.
    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15901-5 PMID: 14665696
Article Info
Journal
Molecular cancer research : MCR
Abbr.
Mol Cancer Res
ISSN
1541-7786
Published
2008-05-00
Pages
760-9
Language
English
Region
United States
NLM ID
101150042
PMCID
PMC2756991
Subset
IM
Grants
NCI NIH HHS · U54 CA112967-02S1 · United States
NCI NIH HHS · R01 CA121941-03 · United States
Howard Hughes Medical Institute · United States
NCI NIH HHS · R01-CA17007 · United States
NCI NIH HHS · R01 CA017007 · United States
NCI NIH HHS · U54 CA112967 · United States
NCI NIH HHS · U54-CA112967 · United States
NCI NIH HHS · U54 CA112967-02 · United States
NCI NIH HHS · R01 CA017007-26 · United States
NCI NIH HHS · R01 CA121941 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com